Erudio Healtherudio.com
Sponsor
University of Utah trials: what clinicians said in public
No HCP commentary report on a trial sponsored by University of Utah yet. Erudio has found public clinician commentary on 4 clinical trials sponsored by University of Utah: NEXT, PemCab, Rad2Nivo and RadSABR. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (University of Utah). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| PemCab NCT03534804 · University of Utah DeepView → | first-line cisplatin-ineligible advanced urothelial carcinoma | Phase 2 | Deep | View | |||
| NEXT NCT03171025 · University of Utah StandardView → | localized muscle-invasive bladder cancer | Phase 2 | Standard | View | |||
| RadSABR NCT03304418 · University of Utah FocusedView → | hormone-naïve oligometastatic prostate cancer to bone | Phase 2 | Focused | View | |||
| Rad2Nivo NCT04109729 · University of Utah FocusedView → | metastatic castration-resistant prostate cancer | Phase 1 | Focused | View | |||